TeselaGen Announces Spin-Off, Built Biotechnologies, Aims to Advance DNA Manufacturing
TeselaGen Biotechnology, Inc., a leader in biological design and process automation, has announced the launch of its spin-off, Built Biotechnologies, Inc., to revolutionize DNA manufacturing. Specializing in advanced DNA workflows crucial for cell and gene therapies and other biotech sectors, Built addresses the challenge of constructing complex DNA molecules, essential for advancing synthetic biology.